1.
Ahmed H, Alabdul Razzak I, Abdulrazzak E, Gomaa S, Almahmood M, Abdelrazeq K, et al. Comparative Outcomes of Glucagon-Like Peptide-1 Receptor Agonists versus Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Cirrhosis. ASIDE GI [Internet]. 2026 Jul. 27 [cited 2026 Jul. 30];2(4):1-7. Available from: https://asidejournals.com/index.php/Gastroenterology/article/view/751